Patent · US Active

Genetically modified non-human animal with human or chimeric CD3e

US12016315B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignees

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN
Biocytogen JiangSu Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yanan Guo · Beijing, CN
Rui Huang · Beijing, CN
Xiaofei Zhou · Beijing, CN
Yang Bai · Beijing, CN
Jiawei Yao · Beijing, CN
Chaoshe Guo · Beijing, CN

Key dates

Filing date	Feb 5, 2021
Grant date	Jun 25, 2024
Priority date	—
Expiry date	Sep 5, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01K2267/0387
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD3e (T-cell surface glycoprotein CD3 epsilon chain), and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.